CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Ho Carole Chief Medical Officer | Option exercise | +17,845 | $0.68 | $12K | 136,655 |
| 2024-11-25 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −17,845 | 107,155 | ||
| 2024-11-22 | Schuth Alexander O. COFO and Secretary | Option exercise | +20,516 | $0.68 | $14K | 198,582 |
| 2024-11-22 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −20,516 | 124,562 | ||
| 2024-11-11 | Schenkein David P Director | Option exercise 10b5-1 | +47,165 | $18.00 | $849K | 68,661 |
| 2024-11-11 | Schenkein David P Director | Sale 10b5-1 | −27,129 | $32.09 | $871K | 41,532 |
| 2024-11-11 | Schenkein David P Director | Sale 10b5-1 | −32,312 | $32.87 | $1.1M | 9,220 |
| 2024-11-11 | Schenkein David P Director | Option exercise · Stock Option (right to buy) 10b5-1 | −47,165 | 0 | ||
| 2024-11-07 | Schuth Alexander O. COFO and Secretary | Option exercise 10b5-1 | +15,558 | $5.28 | $82K | 193,624 |
| 2024-11-07 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −12,333 | $29.68 | $366K | 181,291 |
| 2024-11-07 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,925 | $30.72 | $90K | 178,366 |
| 2024-11-07 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −300 | $31.29 | $9K | 178,066 |
| 2024-11-07 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) 10b5-1 | −15,558 | 53,379 | ||
| 2024-11-07 | SATO VICKI L Director | Sale 10b5-1 | −1,020 | $30.00 | $31K | 111,056 |
| 2024-11-01 | SATO VICKI L Director | Sale 10b5-1 | −3,080 | $27.07 | $83K | 112,076 |
| 2024-10-18 | Watts Ryan J. President and CEO | Option exercise 10b5-1 | +40,000 | $0.68 | $27K | 275,807 |
| 2024-10-18 | Watts Ryan J. President and CEO | Sale 10b5-1 | −40,000 | $27.69 | $1.1M | 235,807 |
| 2024-10-18 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −40,000 | 1,078,091 | ||
| 2024-09-30 | Krognes Steve E. Director | Sale 10b5-1 | −30,000 | $29.03 | $871K | 29,096 |
| 2024-09-13 | SATO VICKI L Director | Sale 10b5-1 | −1,020 | $30.00 | $31K | 115,156 |
Page 5 of 53 · 1,043 trades